Second, we developed a multi-omic assay simultaneously detecting three diverse biomarkers important in cancer diagnostics— exon 19 del DNA, hsa-miR-16 RNA, and IL-8 protein—which we tested by analyzing a synthetic, equimolar mixture of the three targets (Fig. 6d). Here, CXCL8 is linked to cancer.